A study evaluating KTE-X19, a cell therapy infusion for leukemia Research Question:
What is the safety and effectiveness of KTE-X19, a cell therapy (infusion) for patients
with acute lymphoblastic leukemia (ALL)?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
The primary objectives of this study are to determine the safety and effectiveness
of KTE-X19, a cell therapy (infusion) for adult participants with relapsed/refractory
(r/r) B-precursor acute lymphoblastic leukemia (ALL).
Study Reference #: ILEU15075
Lead Researcher (Principal Investigator)
Lead Researcher: Kristen O'Dwyer
Study Contact InformationStudy Coordinator: Haley Misch
Phone: (585) 275-9485
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search